Key terms

About ALEC

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ALEC news

May 08 4:50pm ET Alector reports Q1 EPS (38c), consensus (51c) by TipRanks Mar 21 4:12pm ET Alector Inc Announces Board Retirement and New Members by TipRanks Mar 07 12:06am ET Alector’s Clinical Progress and Financial Health Anchor Buy Recommendation by TipRanks Feb 29 6:40am ET Analysts Offer Insights on Healthcare Companies: DocGo (DCGO), Revance Therapeutics (RVNC) and Alector (ALEC) by TipRanks Feb 28 7:38am ET Optimistic Buy Rating for Alector’s AL002 Based on Promising Alzheimer’s Disease Trial Biomarkers and TREM2 Signaling Efficacy by TipRanks Feb 28 5:37am ET Alector: Cautious Hold Rating Ahead of Key Clinical Trial Milestones and Financial Assessment by TipRanks Feb 28 3:37am ET Alector (ALEC) Receives a Buy from Barclays by TipRanks Feb 27 7:05pm ET TD Cowen Sticks to Their Buy Rating for Alector (ALEC) by TipRanks Feb 27 4:27pm ET Alector reports Q4 EPS (49c), consensus (77c) by TipRanks Feb 13 5:27am ET Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Alector (ALEC) and Cytokinetics (CYTK) by TipRanks Feb 13 5:23am ET Alector’s Promising Pipeline and Market Potential Affirm Buy Rating by TipRanks

No recent press releases are available for ALEC

ALEC Financials

1-year income & revenue

Key terms

ALEC Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ALEC Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Bruce Garelick was found guilty of insider trading
John Minchillo/AP
Investor found guilty in Trump Media insider trading case
People walk toward an entrance to Disneyland in Anaheim, California on April 24, 2023.
Mario Tama/Getty Images/File
Americans are shopping less but they’re still spending on flights, hotels and Disneyland
Scaffolding and construction netting near an apartment building in New York, US, on Wednesday, Oct. 11, 2023. Monthly fees and expenses for inspections, insurance and climate-friendly upgrades are squeezing residents of the city's many co-op and condo buildings. Photographer: Michael Nagle/Bloomberg
Michael Nagle/Bloomberg/Getty Images
For US renters, the chance of owning a home is going from bad to worse
Close-up detail of the Disney+ app icon on an Apple iPhone 12 Pro smartphone screen, on November 11, 2020. (Photo by Phil Barker/Future Publishing via Getty Images)
Phil Barker/Future Publishing/Getty Images
Disney just had its worst day in a year and a half